Literature DB >> 12106872

Cloning, heterologous expression, and substrate specificities of protein farnesyltransferases from Trypanosoma cruzi and Leishmania major.

Frederick S Buckner1, Richard T Eastman, José L Nepomuceno-Silva, Emily C Speelmon, Peter J Myler, Wesley C Van Voorhis, Kohei Yokoyama.   

Abstract

Chagas disease and leishmaniasis are tropical diseases caused by the protozoan parasites, Trypanosoma cruzi and Leishmania species, respectively. Protein farnesyltransferase (PFT) is being investigated as a target for anti-trypanosomatid agents because inhibitors of this enzyme are highly toxic to these parasites compared to mammalian cells. Here, we report the cloning of the alpha- and beta-subunit genes of PFT from T. cruzi and Leishmania major. The proteins encoded by these genes are considerably larger than those of mammalian PFTs due to the presence of a number of inserts of >25 amino acids that map to junctions between helical structural elements. These inserts are not part of the active site or the interface between the two subunits. Northern blots demonstrate expression of messenger RNA for the PFT subunits in both mammalian and insect life-cycle stages of these parasites. The T. cruzi, Trypanosoma brucei, and L. major PFTs were overexpressed in the Sf9 cell/baculovirus system as active enzyme forms. Kinetic studies with a panel of CALX-containing peptides with all 20 amino acids in the X-position show that trypanosomatid PFTs have similar substrate specificities and these are different from the mammalian PFT substrate specificity patterns.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106872     DOI: 10.1016/s0166-6851(02)00099-3

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  9 in total

1.  Manumycin A Is a Potent Inhibitor of Mammalian Thioredoxin Reductase-1 (TrxR-1).

Authors:  Anupama Tuladhar; Kathleen S Rein
Journal:  ACS Med Chem Lett       Date:  2018-03-05       Impact factor: 4.345

2.  Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.

Authors:  Joshua D Ochocki; Mark D Distefano
Journal:  Medchemcomm       Date:  2013-03       Impact factor: 3.597

Review 3.  Benzophenone: a ubiquitous scaffold in medicinal chemistry.

Authors:  Khemchand Surana; Bharatkumar Chaudhary; Monika Diwaker; Satyasheel Sharma
Journal:  Medchemcomm       Date:  2018-08-23       Impact factor: 3.597

4.  Protein geranylgeranyltransferase-I of Trypanosoma cruzi.

Authors:  Kohei Yokoyama; John R Gillespie; Wesley C Van Voorhis; Frederick S Buckner; Michael H Gelb
Journal:  Mol Biochem Parasitol       Date:  2007-10-02       Impact factor: 1.759

5.  The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas disease.

Authors:  Oliver Hucke; Michael H Gelb; Christophe L M J Verlinde; Frederick S Buckner
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

6.  A class of sterol 14-demethylase inhibitors as anti-Trypanosoma cruzi agents.

Authors:  Frederick Buckner; Kohei Yokoyama; Jeffrey Lockman; Kendra Aikenhead; Junko Ohkanda; Martin Sadilek; Said Sebti; Wesley Van Voorhis; Andrew Hamilton; Michael H Gelb
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

7.  Bioactivity of Farnesyltransferase Inhibitors Against Entamoeba histolytica and Schistosoma mansoni.

Authors:  Alexandra Probst; Thi N Nguyen; Nelly El-Sakkary; Danielle Skinner; Brian M Suzuki; Frederick S Buckner; Michael H Gelb; Conor R Caffrey; Anjan Debnath
Journal:  Front Cell Infect Microbiol       Date:  2019-05-29       Impact factor: 5.293

8.  Comparative Genomics of Peroxisome Biogenesis Proteins: Making Sense of the PEX Proteins.

Authors:  Renate L M Jansen; Carlos Santana-Molina; Marco van den Noort; Damien P Devos; Ida J van der Klei
Journal:  Front Cell Dev Biol       Date:  2021-05-20

9.  ProtozoaDB 2.0: A Trypanosoma Brucei Case Study.

Authors:  Rodrigo Jardim; Diogo Tschoeke; Alberto M R Da Vila
Journal:  Pathogens       Date:  2017-07-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.